Manipal Health Enterprises made a positive debut on the Indian stock exchanges on Wednesday, with shares listing at a premium of around 11% over the initial public offering (IPO) price. The strong opening reflects investor interest in one of India’s largest private hospital networks, even as concerns remain about its rich valuation and debt levels.
The Manipal Health share price opened at ₹652 on the National Stock Exchange (NSE), a 10.5% premium to its issue price of ₹590. On the Bombay Stock Exchange (BSE), the stock began trading at ₹655, gaining 11.01%. The shares later touched ₹653.10 on the NSE, taking the company’s market value to about $9 billion.
The market debut came after Manipal Health raised ₹9,275.22 crore through its IPO, making it one of India’s biggest public offerings of 2026. The issue was the country’s second-largest IPO of the year, behind SBI Funds Management. The offering attracted strong institutional demand despite relatively cautious participation from retail investors.
The IPO was open for subscription between July 29 and July 31. It was subscribed 4.92 times overall, with investors bidding for more than 443 million shares against around 90 million shares available after adjustments for anchor investors. Qualified institutional buyers showed the strongest interest, with their portion subscribed 8.25 times. The non-institutional investor category was subscribed 1.02 times, while the retail portion was subscribed 0.93 times.
The difference between institutional and retail demand was partly linked to concerns over Manipal Health’s valuation. At the upper end of its IPO price band, the company was valued at about 84.65 times its projected fiscal 2026 earnings. That was higher than the valuations of major listed hospital companies such as Apollo Hospitals, Fortis Healthcare and Max Healthcare, which were trading at lower earnings multiples.
Still, investors appear willing to pay a premium for Manipal Health’s scale and long-term growth prospects. Backed by Singapore state investment firm Temasek, the company has built a large pan-India healthcare network. It operates 49 hospitals with more than 13,000 beds, making it India’s largest multispecialty hospital network by bed capacity.
The company’s growth has been driven by both expansion and acquisitions. Its network now covers a large part of India’s organised private healthcare market, giving it a presence across multiple cities and regions. This footprint could help Manipal Health benefit from rising demand for specialised medical services as India’s population ages and lifestyle-related and chronic diseases become more common.
The hospital sector has also been attracting increasing attention from global investors. Large investment firms have been putting money into India’s healthcare market, encouraged by rising healthcare spending, greater demand for quality treatment and opportunities to consolidate a fragmented hospital industry. Manipal Health’s listing therefore comes at a time when the broader Indian healthcare sector is attracting strong domestic and international interest.
However, the company’s rapid expansion has also resulted in significant borrowing. A major purpose of the IPO was to strengthen its balance sheet. Manipal Health plans to use a substantial portion of the funds raised to repay or prepay borrowings at its subsidiary, Manipal Hospitals.
The company also intends to use part of the IPO proceeds to acquire a minority stake in Sahyadri Hospitals. The move would strengthen its position in the Indian hospital market while supporting its strategy of expanding through acquisitions and increasing its presence in important healthcare markets.
Manipal Health is not stopping with its current network. The company plans to invest around ₹4,000 crore to expand its bed capacity by more than 18%. The expansion is expected to add about 2,400 beds over the next three to four years. If implemented as planned, the additional capacity could support revenue growth while allowing the hospital chain to serve more patients.
The company’s growth plans put it in direct competition with established listed hospital chains. Apollo Hospitals, Max Healthcare and Fortis Healthcare are among the key players investors will compare Manipal Health with after its listing. Apollo, for instance, currently has nearly 10,000 beds and has set its own target of reaching around 13,000 beds by fiscal 2030.
For investors, the key issue now is whether Manipal Health can maintain its earnings growth quickly enough to support its premium valuation. A strong listing provides an encouraging start, but the company will have to demonstrate that its expansion strategy can translate into sustainable profits, lower debt and stronger cash generation.
The company’s stock market debut nevertheless marks an important milestone for India’s healthcare industry. With more than 13,000 beds, a nationwide network and plans for further expansion, Manipal Health has entered the listed market with considerable scale.
The immediate 11% listing gain shows that investors are confident about the long-term healthcare opportunity in India. But sustaining that confidence will depend on execution. For Manipal Health, the next phase will be about balancing expansion with financial discipline and proving that its growing hospital network can deliver consistent returns to shareholders.